
ANVS
Healthcare · Biotechnology · $39.8M market cap
$0.9261+0.08 (+9.3%)Nov 13, 4:18 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +32.9% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 11, 2026 | Time not confirmed | -0.33 | -0.22 | +33.3% |
| Aug 14, 2026 | Before the open | -0.44 | -0.40 | +9.1% |
| May 15, 2026 | Before the open | -0.35 | -0.63 | -80.0% |
| Mar 23, 2026 | Time not confirmed | -0.31 | -0.39 | -25.8% |
| Nov 12, 2025 | Before the open | -0.37 | -0.37 | 0.0% |
| Aug 12, 2025 | After the close | -0.39 | -0.32 | +17.9% |
| May 8, 2025 | After the close | -0.80 | -0.32 | +60.0% |
| Mar 21, 2025 | After the close | -0.20 | -0.43 | -115.0% |
| Nov 8, 2024 | After the close | -0.60 | -0.97 | -61.7% |
| Aug 14, 2024 | After the close | -0.67 | -0.44 | +34.3% |
| May 10, 2024 | After the close | -0.84 | -0.10 | +88.1% |
| Mar 29, 2024 | After the close | -1.30 | -2.24 | -72.3% |
| Nov 8, 2023 | After the close | -1.09 |
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer's disease, as well as in open-label phase 3 to treat parkinson's disease. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and…
| -1.63 |
| -49.5% |
| Aug 14, 2023 | After the close | -1.14 | -1.07 | +6.1% |
| May 10, 2023 | After the close | -0.59 | -1.19 | -101.7% |
| Mar 1, 2023 | Time not confirmed | -1.05 | -1.05 | 0.0% |
| Nov 8, 2022 | After the close | -1.01 | -0.93 | +7.9% |
| Aug 8, 2022 | After the close | -0.71 | -1.07 | -50.7% |
| May 4, 2022 | After the close | -0.67 | -0.72 | -7.5% |
| Mar 2, 2022 | After the close | -0.25 | -0.75 | -200.0% |
| Nov 3, 2021 | Before the open | -0.44 | -0.35 | +20.5% |
| Jul 28, 2021 | After the close | -0.37 | -0.34 | +8.1% |
| May 6, 2021 | Before the open | -0.46 | -0.46 | 0.0% |
| Mar 3, 2021 | After the close | -0.16 | -0.25 | -56.3% |
| Nov 4, 2020 | After the close | -0.15 | -0.15 | 0.0% |
| Jul 29, 2020 | Before the open | -0.15 | -0.34 | -126.7% |
| May 5, 2020 | After the close | — | -0.10 | — |
| Mar 25, 2020 | After the close | 0.00 | -0.04 | — |
| Jul 3, 2019 | Time not confirmed | — | -0.03 | — |
| May 15, 2019 | Time not confirmed | — | -0.03 | — |